131 related articles for article (PubMed ID: 6210910)
21. The effects of thionapthene-2-carboxylic acid-lysine on the hypercalcemia of malignancy in the rat.
Decker JE; Morrison NE; Lorenzo JA; Samour CM; McCarron BA; Raisz LG
Calcif Tissue Int; 1989 Jan; 44(1):61-4. PubMed ID: 2521808
[TBL] [Abstract][Full Text] [Related]
22. Successful treatment of hypercalcemia by indomethacin in mice bearing a prostaglandin-producing fibrosarcoma.
Tashjian AH; Voelkel EF; Goldhaber P; Levine L
Prostaglandins; 1973 Apr; 3(4):515-24. PubMed ID: 4729590
[No Abstract] [Full Text] [Related]
23. The effect of low calcium diet, mithramycin, and dichlorodimethylene bisphosphonate on humoral hypercalcemia of malignancy in nude mice transplanted with the canine adenocarcinoma tumor line (CAC-8).
Rosol TJ; Capen CC
J Bone Miner Res; 1987 Oct; 2(5):395-405. PubMed ID: 2971305
[TBL] [Abstract][Full Text] [Related]
24. Osseous and intestinal compartments in the humoral hypercalcemia of malignancy associated to Walker 256 tumor in rats.
Torres R; de la Piedra C; Rapado A
Oncology; 1993; 50(2):148-52. PubMed ID: 8451038
[TBL] [Abstract][Full Text] [Related]
25. Prolonged decrease of serum calcium concentration by murine gamma-interferon in hypercalcemic, human tumor (EC-GI)-bearing nude mice.
Sato K; Satoh T; Shizume K; Yamakawa Y; Ono Y; Demura H; Akatsu T; Takahashi N; Suda T
Cancer Res; 1992 Jan; 52(2):444-9. PubMed ID: 1728416
[TBL] [Abstract][Full Text] [Related]
26. Elevated prostaglandin and indomethacin-responsive hypercalcemia in a patient with malignant pheochromocytoma.
Uchida T; Kuwao S; Ishibashi A; Koshiba K
J Urol; 1985 Oct; 134(4):712-3. PubMed ID: 4032577
[No Abstract] [Full Text] [Related]
27. Plasma prostaglandin E in patients with cancer with and without hypercalcemia.
Robertson RP; Baylink DJ; Metz SA; Cummings KB
J Clin Endocrinol Metab; 1976 Dec; 43(6):1330-5. PubMed ID: 1002818
[TBL] [Abstract][Full Text] [Related]
28. Passive immunization with anti-parathyroid hormone-related protein monoclonal antibody markedly prolongs survival time of hypercalcemic nude mice bearing transplanted human PTHrP-producing tumors.
Sato K; Yamakawa Y; Shizume K; Satoh T; Nohtomi K; Demura H; Akatsu T; Nagata N; Kasahara T; Ohkawa H
J Bone Miner Res; 1993 Jul; 8(7):849-60. PubMed ID: 8352067
[TBL] [Abstract][Full Text] [Related]
29. Indomethacin-responsive hypercalcemia in a patient with renal-cell adenocarcinoma.
Brereton HD; Halushka PV; Alexander RW; Mason DM; Keiser HR; DeVita VT
N Engl J Med; 1974 Jun; 291(2):83-5. PubMed ID: 4835887
[TBL] [Abstract][Full Text] [Related]
30. Hypercalcemia with ovarian carcinoma: evidence of a pathogenetic role for prostaglandins.
Josse RG; Wilson DR; Heersche JN; Mills JR; Murray TM
Cancer; 1981 Sep; 48(5):1233-41. PubMed ID: 7272955
[TBL] [Abstract][Full Text] [Related]
31. Systemic effects of the VX2 carcinoma on the osseous skeleton. A quantitative study of trabecular bone.
Wolfe HJ; Bitman WR; Voelkel EF; Griffiths HJ; Tashjian AH
Lab Invest; 1978 Feb; 38(2):208-15. PubMed ID: 628205
[TBL] [Abstract][Full Text] [Related]
32. Prostaglandin E and hypercalcemia in breast carcinoma: only a tumor marker? A need for perspective.
Caro JF; Besarab A; Flynn JT
Am J Med; 1979 Feb; 66(2):337-41. PubMed ID: 218452
[TBL] [Abstract][Full Text] [Related]
33. Association of hypercalcemia with tumors producing colony-stimulating factor(s).
Kondo Y; Sato K; Ohkawa H; Ueyama Y; Okabe T; Sato N; Asano S; Mori M; Ohsawa N; Kosaka K
Cancer Res; 1983 May; 43(5):2368-74. PubMed ID: 6600966
[TBL] [Abstract][Full Text] [Related]
34. Plasma PTH and PTH-rP levels and clodronate therapy in cancer patients with hypercalcemia.
Su RJ; Chang CC; Tsai KS
J Formos Med Assoc; 1993 Nov; 92(11):977-82. PubMed ID: 7910069
[TBL] [Abstract][Full Text] [Related]
35. Humoral hypercalcemia of malignancy. Release of a prostaglandin-stimulating bone-resorbing factor in vitro by human transitional-cell carcinoma cells.
Bringhurst FR; Bierer BE; Godeau F; Neyhard N; Varner V; Segre GV
J Clin Invest; 1986 Feb; 77(2):456-64. PubMed ID: 3003159
[TBL] [Abstract][Full Text] [Related]
36. Prostaglandin-mediated hypercalcemia in transitional cell carcinoma of the bladder.
McKay HA; Gavrell GJ; Meehan WL; Kaplan RA; Le Blanc GA
J Urol; 1978 May; 119(5):689-92. PubMed ID: 660746
[TBL] [Abstract][Full Text] [Related]
37. Extremity metabolism in the cachectic, VX-2 carcinoma-bearing rabbit.
Conlon KC; Bading JR; McDermott EW; Corbally MT; Tolvo AJ; Brennan MF
J Surg Res; 1993 Sep; 55(3):330-7. PubMed ID: 8412119
[TBL] [Abstract][Full Text] [Related]
38. [Treatment of neoplastic hypercalcemia using single-infusion diphosphonate].
Thiébaud D; Jaeger P; Jacquet AF; Burckhardt P
Schweiz Med Wochenschr; 1988 Jan; 118(3):77-81. PubMed ID: 3344411
[TBL] [Abstract][Full Text] [Related]
39. [Value of imaging follow-ups in rabbit spinal metastasis model created by transplantation of VX2 carcinoma under computed tomographic guidance].
Ling L; He SC; Huang H; Zhu HD; Zhang CJ; Fang W; Guo JH; Deng G; Zhu GY; Qin YL; Teng GJ
Zhonghua Yi Xue Za Zhi; 2013 Oct; 93(39):3131-4. PubMed ID: 24417994
[TBL] [Abstract][Full Text] [Related]
40. Effect of gallium nitrate on tamoxifen induced hypercalcemia in rats bearing mammary tumor.
Arumugam G; Shanthi P; Sachdanandam P
Exp Oncol; 2006 Jun; 28(2):141-5. PubMed ID: 16837906
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
